Related Experiment Videos

Ultrastructural study of the retina in late infantile metachromatic leukodystrophy

H H Goebel1, H Busch-Hettwer, J Bohl

  • 1Division of Neuropathology, University of Mainz, FRG.

Ophthalmic Research
|January 1, 1992
PubMed

Insights

Metachromatic leukodystrophy (MLD), a genetic disorder, was found in a child

Area of Science:

  • Neurology
  • Genetics
  • Ophthalmology

Background:

  • Metachromatic leukodystrophy (MLD) is a rare genetic disorder caused by aryl-sulfatase A deficiency.
  • It primarily affects the central and peripheral nervous systems, leading to demyelination and accumulation of metachromatic material.
  • Clinical presentation can vary, and ocular manifestations are not always apparent.

Purpose of the Study:

  • To investigate the ocular pathology in a case of clinically unrecognized metachromatic leukodystrophy (MLD).
  • To determine the specific cellular and molecular changes within the retina in MLD.
  • To elucidate the role of sulfatides in retinal ganglion cells.

Main Methods:

  • Autopsy examination of a 2-year-old girl with undiagnosed MLD.
  • Histopathological analysis of the central and peripheral nervous systems, including the optic nerve and retina.
  • Microscopic examination for demyelination and lysosomal storage bodies.

Main Results:

  • Autopsy revealed MLD with demyelination in the central and peripheral nervous systems.
  • The retina, clinically normal, showed demyelination in the optic nerve and papilla.
  • Intraneuronal storage of MLD-typical lysosomal residual bodies was observed in retinal ganglion cell perikarya, but not in other retinal cells.

Conclusions:

  • MLD affects the optic nerve and retinal ganglion cells, even when clinically undetected.
  • Sulfatides play a specific metabolic role in retinal ganglion cells in the context of MLD.
  • These findings highlight the importance of considering ocular pathology in MLD diagnosis and understanding its specific metabolic pathways.

Related Concept Videos